r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

CH

Christopher Hite

Insider · EVP & Chairman, Partnering · RPRX

Christopher Hite files insider transactions with the SEC as an evp & chairman, partnering of Royalty Pharma (RPRX). We hold 3 disclosed purchases and sales filed since 5 June 2020, 3 of them in the last 90 days.

  • Files forRPRX
  • Disclosed buys and sells3 in all, 3 in the last 90 days
  • Last disclosure19 August 2026

Positions held

4 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 15 June 2020 — 19 August 2026EVP & Chairman, Partnering · Royalty Pharma (RPRX)24 Form 4 lines · source: SEC Form 4
  • Filed 16 April 2026 — 16 April 2026Director · Kailera Therapeutics (KLRA)1 Form 4 line · source: SEC Form 4
  • Filed 5 March 2026 — 5 March 2026Director · Vera Therapeutics (VERA)2 Form 4 lines · source: SEC Form 4
  • Filed 4 June 2020 — 19 November 2021Director · Acceleron Pharma (XLRN)6 Form 4 lines · source: SEC Form 4

Everything they disclosed

33 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.